Genetic variants at PITX2, CAV1 and KCNN3, hypertensive target-organ damage and atrial fibrillation in an Uzbek population
In a study of Uzbek hypertensive patients, specific genetic variants at the PITX2, CAV1, and KCNN3 loci were found to be associated with atrial fibrillation, while the KCNN3 variant rs11264280 was uniquely linked to increased severity of hypertensive target-organ damage even in the absence of the arrhythmia.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
High blood pressure is a common condition that forces the heart to work harder than it should. Over time, this extra strain can cause the heart muscle to thicken, the main arteries to stiffen, and the upper chambers of the heart to stretch. While many people live with high blood pressure for years without developing a specific irregular heartbeat called atrial fibrillation, those who do often suffer from more severe damage to their organs. Scientists have long suspected that genes play a role in why some people with high blood pressure develop this dangerous rhythm disorder while others do not. They also wondered if certain genetic instructions might make the heart and blood vessels more vulnerable to damage even before the irregular heartbeat starts. To understand this, researchers look at tiny variations in DNA, which act like slight typos in the body's instruction manual, to see if these differences correlate with how the heart responds to stress.
A team of researchers in Uzbekistan recently investigated this question by studying hundreds of patients who already had high blood pressure. They focused on a specific group of people from Uzbekistan to fill a gap in global knowledge, as most previous genetic studies on heart disease have been done on people of European or East Asian ancestry. The team gathered 372 patients, dividing them into two groups: those who had developed atrial fibrillation and those who had not. They examined the DNA of each person to look for five specific variations in genes known to be linked to heart rhythm problems. These genes, which include instructions for building proteins that help heart cells communicate and maintain their structure, were chosen because earlier studies had hinted they might be important, though their role in Central Asian populations was unknown.
The researchers found that three of the five genetic variations they checked were strongly linked to the presence of atrial fibrillation in this group. One variation, located near a gene called PITX2, was nearly three times more common in patients with the irregular heartbeat than in those without it. Another variation, found in a gene called CAV1, was actually less common in the patients with the condition, suggesting it might offer some protection. A third variation, located in a region of the genome known as 1q21 near the KCNN3 gene, was also significantly more frequent in those with the arrhythmia. These findings confirmed that these specific genetic markers are relevant for people in Central Asia, just as they are for people in other parts of the world.
However, the most intriguing discovery went beyond simply predicting who would get the irregular heartbeat. The researchers looked closely at the patients who had high blood pressure but did not yet have atrial fibrillation. They found that people carrying a specific version of the KCNN3 gene variation had signs of more severe heart and blood vessel damage, even though they did not have the arrhythmia. Specifically, these individuals had thicker heart muscles and stiffer artery walls compared to their peers with the same blood pressure levels but different genes. This suggests that this particular genetic variation might influence how the body reacts to high blood pressure, causing structural damage to the heart and vessels earlier in the disease process. It implies that the genetic risk is not just about whether the irregular heartbeat will start, but also about how much harm the high blood pressure does to the body before that happens.
The study also revealed that the frequency of these genetic variations in the Uzbek population was different from what is seen in other parts of the world. For instance, the specific version of the KCNN3 gene that was linked to both the irregular heartbeat and the organ damage was more common in this Uzbek group than in any of the major global populations previously recorded. This highlights the importance of studying diverse groups of people, as genetic risks can vary significantly depending on ancestry. While the study provides a clear picture of these associations, the researchers note that their work is a first step. Because the study looked at patients at a single point in time, it cannot prove that the genes caused the damage, only that they are linked to it. The team emphasizes that these findings need to be confirmed by other studies in different groups of people to ensure the results are reliable and to better understand how these genetic factors interact with the environment and lifestyle.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.